Neutrophil and platelet activation at balloon-injured coronary artery plaque in patients undergoing angioplasty

Journal of the American College of Cardiology

Volumn 27, Issue 4, 1996, Pages 819-824

  Neumann, Franz Josef ^a   Ott, Ilka ^b   Gawaz, Meinrad ^b   Puchner, Georg ^b   Schömig, Albert ^b  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; FIBRINOGEN RECEPTOR; L SELECTIN;

ADULT; AGED; ARTICLE; ATHEROSCLEROTIC PLAQUE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; FEMALE; HUMAN; LEUKOCYTE ACTIVATION; MALE; PATHOGENESIS; PRIORITY JOURNAL; THROMBOCYTE ACTIVATION; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 0029981407     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/0735-1097(95)00563-3     Document Type: Article

References (30)

1. Steele PM, Chesebro JH, Stanson AW, et al. Balloon angioplasty: natural history of the pathophysiological response to injury in a pig model. Circ Res 1985;57:105-12.
2. Wilcox JN, Smith KM, Schwartz S, Gordon D. Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. Proc Natl Acad Sci USA 1986;134:1087-97.
3. Scott CF, Purdon AD, Silver LD, Colman RW. Cleavage of high molecular weight kininogen (HMWK) by plasma factor XIa. J Biol Chem 1985;260: 10856-63.
4. Kaplan AV, Leung LL, Leung WH, Grant GW, McDougall IR, Fischell TA. Roles of thrombin and platelet membrane glycoprotein IIb/IIIa in platelet-subendothelial deposition after angioplasty in an ex vivo whole artery model. Circulation 1991;84:1279-88.
5. Meloni FJ, Schmaier AH. Low molecular weight kininogen binds to platelets to modulate thrombin-induced platelet activation. J Biol Chem 1991;266: 6786-94.
6. Regoli D, Barabe J. Pharmacology of bradykinin and related kinins. J Pharmacol Rev 1980;32:1-45.
7. Bizios R, Lai L, Fenton JW II, Malik AB. Thrombin-induced chemotaxis and aggregation of neutrophils. J Cell Physiol 1986;128:485-90.
8. Bar-Shavit R, Kahn A, Wildner GD, Fenton JW II. Monocyte chemotaxis: stimulation by specific exosite region in thrombin. Science 1983;220:728-31.
9. Ruf W, Edgington TS. Structural biology of tissue factor, the initiator of thrombogenesis in vivo. FASEB J 1994;8:385-90.
10. Edwards RL, Rickles FR. The role of leukocytes in the activation of blood coagulation. Semin Hematol 1992;29:202-12.
11. Ip JH, Fuster V, Israel D, Badimon L, Badimon J, Chesebro JH. The role of platelets, thrombin and hyperplasia in restenosis after coronary angioplasty. J Am Coll Cardiol 1991;17:77B-88B.
12. Liu MW, Roubin GS, King SB. Restenosis after coronary angioplasty. Potential biologic determinants and role of intimai hyperplasia. Circulation 1989;79:1374-87.
13. Block PC, Myler RK, Stertzer S, Fallon JR. Morphology after transluminal angioplasty in human beings. N Engl J Med 1982;305:382-6.
14. Gasperetti CM, Gonias SL, Gimple LW, Powers ER, Platelet activation during coronary angioplasty in humans. Circulation 1993;88:2728-34.
15. Scharf RE, Tomer A, Marzec UM, Teirstein PS, Ruggeri ZM, Harker LA. Activation of platelets in blood perfusing angioplasty-damaged coronary arteries. Arterioscler Thromb Vasc Biol 1992;12:1475-87.
16. Neumann FJ, Richardt G, Schneider M, et al. Cardiac release of chemoattractants after ischaemia induced by coronary balloon angioplasty. Br Heart J 1993;70:27-34.
17. De Servi S, Mazzone A, Ricevuti G, et al. Granulocyte activation after coronary angioplasty in humans. Circulation 1990;82:140-6.
18. Kujjpers TW, Tool ATJ, Van der School K, et al. Membrane surface antigen expression on neutrophils: a reappraisal of the use of surface markers for neutrophil activation. Blood 1991;78:1105-11.
19. Shattil SJ, Cunningham M, Hoxie JA. Detection of activated platelets in whole blood using activation-dependent monoclonal antibodies and flow cytometry. Blood 1987;70:307-15.
20. Ellis SC, Vandormael SC, Cowley MJ, et al. Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel disease. Circulation 1990;82:1193-203.
21. Kastrati A, Schömig A, Dietz R, Neumann FJ, Richardt G. Time course of restenosis during the first year after emergency coronary stenting. Circulation 1993;87:1498-505.
22. Gawaz MP, Dobos G, Späth M, Mujais SK. Platelet membrane glycoprotein GPIIb-IIIa function is impaired in endstage renal failure. J Am Soc Nephrol 1994;5:36-46.
23. Neumann FJ, Ott I, Gawaz M, et al. Cardiac release of cytokines and inflammatory responses in acute myocardial infarction. Circulation 1995;92: 748-55.
24. Gawaz MP, Neumann FJ, Ott I. Schiessler A, Schomig A. Platelet function in acute myocardial infarction treated by direct angioplasty. Circulation 1996;93:229-37.
25. Alexander RW, Inflammation and coronary artery disease. N Engl J Med 1994;331:468-9.
26. Barath P, Fishbein MC, Coa J, Berenson J, Helfant RH, Forrester JF. Detection and localization of tumor necrosis factor in human atheroma. Am J Cardiol 1990;65:297-302.
27. Entman ML, Ballantyne CM. Inflammation in acute coronary syndromes. Circulation 1993;88:800-3.
28. Westlin WF, Gimbrone MAJ. Neutrophil-mediated damage to human vascular endothelium. Role of cytokine activation. Am J Pathol 1993;142: 117-28.
29. Bone RC. Toward an epidemiology and natural history of SIRS (systemic inflammatory response syndrome). JAMA 1992;268:3452-5.
30. Liuzzo G, Biasucci L, Gallimore J, et al. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. N Engl J Med 1994;331:417-24.